|3Oct 5, 10:52 AM ET

Health Sciences Center LLC 3

3 · Oncolix, Inc. · Filed Oct 5, 2017

Insider Transaction Report

Form 3
Period: 2017-09-21
Holdings
  • Common Stock

    48,000,000
  • Series A Preferred Stock

    19,938,500
  • Warrant to acquire Series A Preferred

    Exercise: $0.08From: 2017-09-21Exp: 2020-01-16Series A Preferred Stock (19,938,500 underlying)
Footnotes (1)
  • [F1]Filer received these securities pursuant to an Assignment and Assumption Agreement dated as of September 21, 2017 between Filer and Greenville Health Research Development Corporation (GHRDC) in which Filer received all the assets and obligations of GHRDC upon the liquidation of GHRDC.

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT